Portfolio company
Entera Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops oral tablet versions of peptide and protein replacement therapies for patients with osteoporosis, hypoparathyroidism, and other metabolic conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Radius Health
This biopharmaceutical company develops and commercialises endocrine therapies for patients with osteoporosis and other bone health conditions.
Epicyt Pharma
This company develops pharmaceutical treatments to restore intestinal calcium absorption for patients with osteoporosis or those who have undergone gastric bypass surgery.
Amolyt Pharma
This clinical-stage biopharmaceutical company develops therapeutic peptides to treat patients with rare endocrine and related diseases, including hypoparathyroidism and acromegaly.
Enthera Pharmaceuticals
This biotech company develops monoclonal antibodies and fusion proteins for patients with autoimmune conditions including type 1 diabetes and inflammatory bowel disease.
Biograil
This biotech company develops a capsule device that enables oral delivery of injectable biologic drugs for pharmaceutical firms and patients.
Entrada Therapeutics
This biopharmaceutical company develops intracellular medicines for patients with neuromuscular and rare diseases using its proprietary endosomal escape vehicle delivery platform.
EnteroBiotix
This biopharmaceutical company develops orally administered microbial therapeutics for patients with gastrointestinal diseases, including irritable bowel syndrome and blood cancers.
Enterbiotix
This company develops orally administered microbiome therapeutics to treat patients with gastrointestinal conditions including irritable bowel syndrome and liver cirrhosis.
